Zydus Lifesciences has ₹36-cr tax demand scrapped; ₹4-cr liability stands
The company had earlier received multiple show-cause notices from the central excise and service tax authorities regarding alleged wrongful availment of CENVAT credit on input services for the period March 2008 to June 2017. Shares of Zydus Lifesciences Ltd ended at ₹1,018.90, down by ₹16.30 or 1.57%, on the BSE today, September 25.

What's Your Reaction?






